PARKINSON'S DISEASE: GAINING SYMPTOMATIC CONTROL WHO IS RESPONSIBLE?
PARKINSON'S DISEASE: GAINING SYMPTOMATIC CONTROL WHO IS RESPONSIBLE? A National Editorial Teleconference Sponsored by The Du Pont Merck Pharmaceutical Company WHAT: -- Leading neurologists highlight new data from a special issue of Neurology, official journal of the American Academy of Neurology -- Facts about benefits and challenges of conversion from standard Carbidopa-Levodopa therapy to sustained release treatment -- Patients discuss how new therapy enhances their lives WHY: -- Role of Neurologists: Pass on experience with new advanced therapy to primary care physicians -- Role of Family Physicians: Provide long-term care with most recent treatment -- Benefit: Many Parkinson's patients will gain more freedom from symptoms and require less frequent dosing with the first sustained release treatment for signs and symptoms of Parkinson's disease WHO: Leading Movement Disorder Specialists And Patients: -- William Koller, M.D., Ph.D. Professor and Chairman of Neurology Kansas University Medical Center -- Margery Mark, M.D. Assistant Professor of Neurology UMDNJ-Robert Wood Johnson Medical School -- Robert Glaser Parkinson's disease patient WHEN: 10 a.m., Wednesday, April 22 WHERE: From your office desk via ATT teleconference hook-up CONTACT: Patty Bifulco, 212-468-3259, to arrange your telephone link-up. -0- 4/20/92
CO: ST: IN: MTC SU:
SM-LR -- NY094 -- 0302 04/20/92 18:49 EDT
|Printer friendly Cite/link Email Feedback|
|Date:||Apr 20, 1992|
|Previous Article:||EPE ANNOUNCES 1991 FINANCIAL RESULTS|
|Next Article:||UNION CARBIDE REPORTS FIRST QUARTER RESULTS|